TWD 46.65
(0.43%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 793.77 Million TWD | 25.21% |
2022 | 633.96 Million TWD | 21.37% |
2021 | 522.33 Million TWD | 41.82% |
2020 | 368.3 Million TWD | 12.21% |
2019 | 328.23 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 118.38 Million TWD | -35.29% |
2024 Q2 | 115.9 Million TWD | -2.1% |
2023 Q2 | 231.89 Million TWD | 26.19% |
2023 Q4 | 182.94 Million TWD | -6.26% |
2023 FY | 793.77 Million TWD | 25.21% |
2023 Q1 | 183.76 Million TWD | 7.98% |
2023 Q3 | 195.16 Million TWD | -15.84% |
2022 Q3 | 166.14 Million TWD | 0.0% |
2022 FY | 633.96 Million TWD | 21.37% |
2022 Q4 | 170.19 Million TWD | 2.44% |
2021 FY | 522.33 Million TWD | 41.82% |
2020 FY | 368.3 Million TWD | 12.21% |
2019 FY | 328.23 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | -10.18% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | -192.227% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 85.582% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 84.558% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 82.714% |
Center Laboratories, Inc. | 1.39 Billion TWD | 43.058% |
Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | -72.561% |
Orient Pharma Co., Ltd. | 889.91 Million TWD | 10.804% |
InnoPharmax Inc. | 46.07 Million TWD | -1622.853% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | -30.832% |
Excelsior Biopharma Inc. | 771.56 Million TWD | -2.878% |
DV Biomed Co., Ltd. | 1.53 Billion TWD | 48.401% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -306.982% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 28.251% |
UniPharma Co., Ltd. | 103.22 Million TWD | -668.993% |
Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | 15.551% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | -69.149% |
Winston Medical Supply Co., Ltd. | 709.07 Million TWD | -11.945% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -76741.239% |
Bioray Biotech Co., Ltd | 191.83 Million TWD | -313.788% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | 2.115% |